カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のエスシタロプラムシュウ酸塩市場2022年：経口液剤、錠剤、その他

◆英語タイトル：Global Escitalopram Oxalate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8808 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：97 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥501,120	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥751,680	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,002,240	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

エスシタロプラムシュウ酸塩は、抗うつ薬の一種であり、主にうつ病や不安障害の治療に使用される選択的セロトニン再取り込み阻害剤（SSRI）に分類される薬剤です。この薬剤は、特にうつ病の症状を和らげる効果が期待されており、多くの臨床研究でその有効性が確認されています。ここでは、エスシタロプラムシュウ酸塩について、定義、特徴、用途、関連技術などについて詳しく解説いたします。

エスシタロプラムシュウ酸塩は、化学的にエスシタロプラムという物質のシュウ酸塩の形態をとっており、具体的には抗うつ作用を持つエナンチオマーの一つであるため、同様の化合物に比べて高い効果を示すことが特徴です。エスシタロプラムは、セロトニンの神経伝達を改善することで、脳内のセロトニン濃度を増加させ、結果的に気分を安定させたり、焦燥感を軽減させたりすることに寄与します。このようなメカニズムは、多くの精神疾患において重要な役割を果たしています。

エスシタロプラムシュウ酸塩の主な用途は、うつ病の治療です。うつ病は、慢性的な気分の落ち込みや興味喪失、エネルギーの低下といった症状を伴うことが多く、日常生活に大きな影響を及ぼします。加えて、エスシタロプラムシュウ酸塩は、全般性不安障害（GAD）、社交不安障害、パニック障害などの不安に関連する疾患の治療にも用いられています。これらの疾患は、心の健康に深く関与し、患者の生活の質を著しく下げる要因となります。そのため、エスシタロプラムシュウ酸塩の適切な使用は、精神的な健康を維持するために不可欠です。

また、エスシタロプラムシュウ酸塩は、用量調整の容易さや副作用の比較的少なさから、広く処方されています。一般的には、初期用量としては10mgから始まり、症状の改善状況に応じて最大で20mgまで増量されることがあります。効果が現れるまでには通常いくつかの週間が必要ですが、患者によって個人差があります。そのため、医療提供者との密なコミュニケーションが不可欠です。

副作用に関しては、エスシタロプラムシュウ酸塩は一般的には比較的穏やかな方に分類されるものの、いくつかの注意が必要な副作用が存在します。最も一般的な副作用には、吐き気、眠気、口の渇き、性機能障害などがあります。特に性機能障害は、患者の生活の質に大きな影響を与える可能性があり、必要に応じて医師と相談することが重要です。また、突然の服用中止は、離脱症状を引き起こす可能性があるため、医師の指示に従って徐々に減薬することが望ましいとされています。

エスシタロプラムシュウ酸塩は、他の抗うつ薬や不安薬とも併用されることがありますが、薬剤相互作用についても十分な注意が必要です。例えば、特定の抗菌薬や抗真菌薬、抗てんかん薬との併用は注意が必要であり、医師が適切な判断を下すことが必要です。患者の既往歴や他に服用している薬剤に基づいて、個別にリスクを評価することが大切です。

精神的な健康に注目が集まる現代において、エスシタロプラムシュウ酸塩の研究は続いています。新たな治療法の開発や、症状に対する理解を深めるための研究は、精神疾患に苦しむ人々の支援に繋がることが期待されています。さらに、精神的健康の課題解決に向けた新しい知見が得られることで、エスシタロプラムシュウ酸塩の使用がさらに効果的に進化していく可能性もあります。

関連技術として、抗うつ薬の効果を測定するためのバイオマーカーの研究や、個別化医療の進展が挙げられます。個別化医療により、患者一人ひとりに合った治療法を選択することが可能になり、より良い治療成果が得られることが期待されています。さらに、精神的な健康を保持するためには、薬物療法だけでなく、心理療法や生活習慣の改善も重要であり、包括的なアプローチが必要です。

このように、エスシタロプラムシュウ酸塩は、うつ病や不安障害の治療において重要な役割を果たし、広く使用されている薬剤です。その特徴や用途、副作用、関連技術について理解を深めることで、患者自身やその周囲の人々がより良い精神的健康を維持する手助けになることを願っています。治療を受ける際には、医療提供者とのコミュニケーションを大切にし、自分に合った治療法を見つけることが重要です。

エスシタロプラムシュウ酸塩市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のエスシタロプラムシュウ酸塩の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

エスシタロプラムシュウ酸塩市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・経口液剤、錠剤、その他

用途別セグメントは次のように区分されます。
・うつ病治療、強迫性障害治療、不安神経症治療、その他

世界のエスシタロプラムシュウ酸塩市場の主要な市場プレーヤーは以下のとおりです。
・Xian.-Janssen、JEWIM PHARMA、Ke Lun、Dr Reddy's、HUAHAI PHARMACEUTICAL、Nishchem International Pvt

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、エスシタロプラムシュウ酸塩製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエスシタロプラムシュウ酸塩メーカーの企業概要、2019年～2022年までのエスシタロプラムシュウ酸塩の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエスシタロプラムシュウ酸塩メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別エスシタロプラムシュウ酸塩の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのエスシタロプラムシュウ酸塩の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのエスシタロプラムシュウ酸塩市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびエスシタロプラムシュウ酸塩の産業チェーンを掲載しています。
・第13、14、15章では、エスシタロプラムシュウ酸塩の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Xian.-Janssen、JEWIM PHARMA、Ke Lun、Dr Reddy's、HUAHAI PHARMACEUTICAL、Nishchem International Pvt
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：経口液剤、錠剤、その他
・用途別分析2017年-2028年：うつ病治療、強迫性障害治療、不安神経症治療、その他
・エスシタロプラムシュウ酸塩の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・エスシタロプラムシュウ酸塩のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・エスシタロプラムシュウ酸塩のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・エスシタロプラムシュウ酸塩の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・エスシタロプラムシュウ酸塩の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Escitalopram Oxalate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Escitalopram Oxalate market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Treat Depression accounting for % of the Escitalopram Oxalate global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral Liquid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Escitalopram Oxalate include Xian.-Janssen, JEWIM PHARMA, Ke Lun, Dr Reddy’s, and HUAHAI PHARMACEUTICAL, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Escitalopram Oxalate market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Liquid
Tablet
Other
Market segment by Application can be divided into
Treat Depression
Treat Obsessive-Compulsive Disorder
Treat Anxiety
Others
The key market players for global Escitalopram Oxalate market are listed below:
Xian.-Janssen
JEWIM PHARMA
Ke Lun
Dr Reddy’s
HUAHAI PHARMACEUTICAL
Nishchem International Pvt
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Escitalopram Oxalate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Escitalopram Oxalate, with price, sales, revenue and global market share of Escitalopram Oxalate from 2019 to 2022.
Chapter 3, the Escitalopram Oxalate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Escitalopram Oxalate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Escitalopram Oxalate market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Escitalopram Oxalate.
Chapter 13, 14, and 15, to describe Escitalopram Oxalate sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Escitalopram Oxalate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Escitalopram Oxalate Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral Liquid
1.2.3 Tablet
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Escitalopram Oxalate Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Treat Depression
1.3.3 Treat Obsessive-Compulsive Disorder
1.3.4 Treat Anxiety
1.3.5 Others
1.4 Global Escitalopram Oxalate Market Size & Forecast
1.4.1 Global Escitalopram Oxalate Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Escitalopram Oxalate Sales in Volume (2017-2028)
1.4.3 Global Escitalopram Oxalate Price (2017-2028)
1.5 Global Escitalopram Oxalate Production Capacity Analysis
1.5.1 Global Escitalopram Oxalate Total Production Capacity (2017-2028)
1.5.2 Global Escitalopram Oxalate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Escitalopram Oxalate Market Drivers
1.6.2 Escitalopram Oxalate Market Restraints
1.6.3 Escitalopram Oxalate Trends Analysis
2 Manufacturers Profiles
2.1 Xian.-Janssen
2.1.1 Xian.-Janssen Details
2.1.2 Xian.-Janssen Major Business
2.1.3 Xian.-Janssen Escitalopram Oxalate Product and Services
2.1.4 Xian.-Janssen Escitalopram Oxalate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 JEWIM PHARMA
2.2.1 JEWIM PHARMA Details
2.2.2 JEWIM PHARMA Major Business
2.2.3 JEWIM PHARMA Escitalopram Oxalate Product and Services
2.2.4 JEWIM PHARMA Escitalopram Oxalate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ke Lun
2.3.1 Ke Lun Details
2.3.2 Ke Lun Major Business
2.3.3 Ke Lun Escitalopram Oxalate Product and Services
2.3.4 Ke Lun Escitalopram Oxalate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Dr Reddy’s
2.4.1 Dr Reddy’s Details
2.4.2 Dr Reddy’s Major Business
2.4.3 Dr Reddy’s Escitalopram Oxalate Product and Services
2.4.4 Dr Reddy’s Escitalopram Oxalate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 HUAHAI PHARMACEUTICAL
2.5.1 HUAHAI PHARMACEUTICAL Details
2.5.2 HUAHAI PHARMACEUTICAL Major Business
2.5.3 HUAHAI PHARMACEUTICAL Escitalopram Oxalate Product and Services
2.5.4 HUAHAI PHARMACEUTICAL Escitalopram Oxalate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Nishchem International Pvt
2.6.1 Nishchem International Pvt Details
2.6.2 Nishchem International Pvt Major Business
2.6.3 Nishchem International Pvt Escitalopram Oxalate Product and Services
2.6.4 Nishchem International Pvt Escitalopram Oxalate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Escitalopram Oxalate Breakdown Data by Manufacturer
3.1 Global Escitalopram Oxalate Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Escitalopram Oxalate Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Escitalopram Oxalate
3.4 Market Concentration Rate
3.4.1 Top 3 Escitalopram Oxalate Manufacturer Market Share in 2021
3.4.2 Top 6 Escitalopram Oxalate Manufacturer Market Share in 2021
3.5 Global Escitalopram Oxalate Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Escitalopram Oxalate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Escitalopram Oxalate Market Size by Region
4.1.1 Global Escitalopram Oxalate Sales in Volume by Region (2017-2028)
4.1.2 Global Escitalopram Oxalate Revenue by Region (2017-2028)
4.2 North America Escitalopram Oxalate Revenue (2017-2028)
4.3 Europe Escitalopram Oxalate Revenue (2017-2028)
4.4 Asia-Pacific Escitalopram Oxalate Revenue (2017-2028)
4.5 South America Escitalopram Oxalate Revenue (2017-2028)
4.6 Middle East and Africa Escitalopram Oxalate Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Escitalopram Oxalate Sales in Volume by Type (2017-2028)
5.2 Global Escitalopram Oxalate Revenue by Type (2017-2028)
5.3 Global Escitalopram Oxalate Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Escitalopram Oxalate Sales in Volume by Application (2017-2028)
6.2 Global Escitalopram Oxalate Revenue by Application (2017-2028)
6.3 Global Escitalopram Oxalate Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Escitalopram Oxalate Sales by Type (2017-2028)
7.2 North America Escitalopram Oxalate Sales by Application (2017-2028)
7.3 North America Escitalopram Oxalate Market Size by Country
7.3.1 North America Escitalopram Oxalate Sales in Volume by Country (2017-2028)
7.3.2 North America Escitalopram Oxalate Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Escitalopram Oxalate Sales by Type (2017-2028)
8.2 Europe Escitalopram Oxalate Sales by Application (2017-2028)
8.3 Europe Escitalopram Oxalate Market Size by Country
8.3.1 Europe Escitalopram Oxalate Sales in Volume by Country (2017-2028)
8.3.2 Europe Escitalopram Oxalate Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Escitalopram Oxalate Sales by Type (2017-2028)
9.2 Asia-Pacific Escitalopram Oxalate Sales by Application (2017-2028)
9.3 Asia-Pacific Escitalopram Oxalate Market Size by Region
9.3.1 Asia-Pacific Escitalopram Oxalate Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Escitalopram Oxalate Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Escitalopram Oxalate Sales by Type (2017-2028)
10.2 South America Escitalopram Oxalate Sales by Application (2017-2028)
10.3 South America Escitalopram Oxalate Market Size by Country
10.3.1 South America Escitalopram Oxalate Sales in Volume by Country (2017-2028)
10.3.2 South America Escitalopram Oxalate Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Escitalopram Oxalate Sales by Type (2017-2028)
11.2 Middle East & Africa Escitalopram Oxalate Sales by Application (2017-2028)
11.3 Middle East & Africa Escitalopram Oxalate Market Size by Country
11.3.1 Middle East & Africa Escitalopram Oxalate Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Escitalopram Oxalate Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Escitalopram Oxalate and Key Manufacturers
12.2 Manufacturing Costs Percentage of Escitalopram Oxalate
12.3 Escitalopram Oxalate Production Process
12.4 Escitalopram Oxalate Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Escitalopram Oxalate Typical Distributors
13.3 Escitalopram Oxalate Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Escitalopram Oxalate Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Escitalopram Oxalate Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Xian.-Janssen Basic Information, Manufacturing Base and Competitors
Table 4. Xian.-Janssen Major Business
Table 5. Xian.-Janssen Escitalopram Oxalate Product and Services
Table 6. Xian.-Janssen Escitalopram Oxalate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. JEWIM PHARMA Basic Information, Manufacturing Base and Competitors
Table 8. JEWIM PHARMA Major Business
Table 9. JEWIM PHARMA Escitalopram Oxalate Product and Services
Table 10. JEWIM PHARMA Escitalopram Oxalate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ke Lun Basic Information, Manufacturing Base and Competitors
Table 12. Ke Lun Major Business
Table 13. Ke Lun Escitalopram Oxalate Product and Services
Table 14. Ke Lun Escitalopram Oxalate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Dr Reddy's Basic Information, Manufacturing Base and Competitors
Table 16. Dr Reddy's Major Business
Table 17. Dr Reddy's Escitalopram Oxalate Product and Services
Table 18. Dr Reddy's Escitalopram Oxalate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. HUAHAI PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 20. HUAHAI PHARMACEUTICAL Major Business
Table 21. HUAHAI PHARMACEUTICAL Escitalopram Oxalate Product and Services
Table 22. HUAHAI PHARMACEUTICAL Escitalopram Oxalate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Nishchem International Pvt Basic Information, Manufacturing Base and Competitors
Table 24. Nishchem International Pvt Major Business
Table 25. Nishchem International Pvt Escitalopram Oxalate Product and Services
Table 26. Nishchem International Pvt Escitalopram Oxalate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Escitalopram Oxalate Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Escitalopram Oxalate Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Escitalopram Oxalate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Escitalopram Oxalate Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Escitalopram Oxalate Production Site of Key Manufacturer
Table 32. Escitalopram Oxalate New Entrant and Capacity Expansion Plans
Table 33. Escitalopram Oxalate Mergers & Acquisitions in the Past Five Years
Table 34. Global Escitalopram Oxalate Sales by Region (2017-2022) & (K Units)
Table 35. Global Escitalopram Oxalate Sales by Region (2023-2028) & (K Units)
Table 36. Global Escitalopram Oxalate Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Escitalopram Oxalate Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Escitalopram Oxalate Sales by Type (2017-2022) & (K Units)
Table 39. Global Escitalopram Oxalate Sales by Type (2023-2028) & (K Units)
Table 40. Global Escitalopram Oxalate Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Escitalopram Oxalate Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Escitalopram Oxalate Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Escitalopram Oxalate Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Escitalopram Oxalate Sales by Application (2017-2022) & (K Units)
Table 45. Global Escitalopram Oxalate Sales by Application (2023-2028) & (K Units)
Table 46. Global Escitalopram Oxalate Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Escitalopram Oxalate Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Escitalopram Oxalate Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Escitalopram Oxalate Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Escitalopram Oxalate Sales by Country (2017-2022) & (K Units)
Table 51. North America Escitalopram Oxalate Sales by Country (2023-2028) & (K Units)
Table 52. North America Escitalopram Oxalate Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Escitalopram Oxalate Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Escitalopram Oxalate Sales by Type (2017-2022) & (K Units)
Table 55. North America Escitalopram Oxalate Sales by Type (2023-2028) & (K Units)
Table 56. North America Escitalopram Oxalate Sales by Application (2017-2022) & (K Units)
Table 57. North America Escitalopram Oxalate Sales by Application (2023-2028) & (K Units)
Table 58. Europe Escitalopram Oxalate Sales by Country (2017-2022) & (K Units)
Table 59. Europe Escitalopram Oxalate Sales by Country (2023-2028) & (K Units)
Table 60. Europe Escitalopram Oxalate Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Escitalopram Oxalate Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Escitalopram Oxalate Sales by Type (2017-2022) & (K Units)
Table 63. Europe Escitalopram Oxalate Sales by Type (2023-2028) & (K Units)
Table 64. Europe Escitalopram Oxalate Sales by Application (2017-2022) & (K Units)
Table 65. Europe Escitalopram Oxalate Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Escitalopram Oxalate Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Escitalopram Oxalate Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Escitalopram Oxalate Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Escitalopram Oxalate Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Escitalopram Oxalate Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Escitalopram Oxalate Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Escitalopram Oxalate Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Escitalopram Oxalate Sales by Application (2023-2028) & (K Units)
Table 74. South America Escitalopram Oxalate Sales by Country (2017-2022) & (K Units)
Table 75. South America Escitalopram Oxalate Sales by Country (2023-2028) & (K Units)
Table 76. South America Escitalopram Oxalate Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Escitalopram Oxalate Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Escitalopram Oxalate Sales by Type (2017-2022) & (K Units)
Table 79. South America Escitalopram Oxalate Sales by Type (2023-2028) & (K Units)
Table 80. South America Escitalopram Oxalate Sales by Application (2017-2022) & (K Units)
Table 81. South America Escitalopram Oxalate Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Escitalopram Oxalate Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Escitalopram Oxalate Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Escitalopram Oxalate Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Escitalopram Oxalate Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Escitalopram Oxalate Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Escitalopram Oxalate Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Escitalopram Oxalate Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Escitalopram Oxalate Sales by Application (2023-2028) & (K Units)
Table 90. Escitalopram Oxalate Raw Material
Table 91. Key Manufacturers of Escitalopram Oxalate Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Escitalopram Oxalate Typical Distributors
Table 95. Escitalopram Oxalate Typical Customers
List of Figures
Figure 1. Escitalopram Oxalate Picture
Figure 2. Global Escitalopram Oxalate Revenue Market Share by Type in 2021
Figure 3. Oral Liquid
Figure 4. Tablet
Figure 5. Other
Figure 6. Global Escitalopram Oxalate Revenue Market Share by Application in 2021
Figure 7. Treat Depression
Figure 8. Treat Obsessive-Compulsive Disorder
Figure 9. Treat Anxiety
Figure 10. Others
Figure 11. Global Escitalopram Oxalate Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Escitalopram Oxalate Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Escitalopram Oxalate Sales (2017-2028) & (K Units)
Figure 14. Global Escitalopram Oxalate Price (2017-2028) & (US$/Unit)
Figure 15. Global Escitalopram Oxalate Production Capacity (2017-2028) & (K Units)
Figure 16. Global Escitalopram Oxalate Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Escitalopram Oxalate Market Drivers
Figure 18. Escitalopram Oxalate Market Restraints
Figure 19. Escitalopram Oxalate Market Trends
Figure 20. Global Escitalopram Oxalate Sales Market Share by Manufacturer in 2021
Figure 21. Global Escitalopram Oxalate Revenue Market Share by Manufacturer in 2021
Figure 22. Escitalopram Oxalate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Escitalopram Oxalate Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Escitalopram Oxalate Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Escitalopram Oxalate Sales Market Share by Region (2017-2028)
Figure 26. Global Escitalopram Oxalate Revenue Market Share by Region (2017-2028)
Figure 27. North America Escitalopram Oxalate Revenue (2017-2028) & (USD Million)
Figure 28. Europe Escitalopram Oxalate Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Escitalopram Oxalate Revenue (2017-2028) & (USD Million)
Figure 30. South America Escitalopram Oxalate Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Escitalopram Oxalate Revenue (2017-2028) & (USD Million)
Figure 32. Global Escitalopram Oxalate Sales Market Share by Type (2017-2028)
Figure 33. Global Escitalopram Oxalate Revenue Market Share by Type (2017-2028)
Figure 34. Global Escitalopram Oxalate Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Escitalopram Oxalate Sales Market Share by Application (2017-2028)
Figure 36. Global Escitalopram Oxalate Revenue Market Share by Application (2017-2028)
Figure 37. Global Escitalopram Oxalate Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Escitalopram Oxalate Sales Market Share by Type (2017-2028)
Figure 39. North America Escitalopram Oxalate Sales Market Share by Application (2017-2028)
Figure 40. North America Escitalopram Oxalate Sales Market Share by Country (2017-2028)
Figure 41. North America Escitalopram Oxalate Revenue Market Share by Country (2017-2028)
Figure 42. United States Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Escitalopram Oxalate Sales Market Share by Type (2017-2028)
Figure 46. Europe Escitalopram Oxalate Sales Market Share by Application (2017-2028)
Figure 47. Europe Escitalopram Oxalate Sales Market Share by Country (2017-2028)
Figure 48. Europe Escitalopram Oxalate Revenue Market Share by Country (2017-2028)
Figure 49. Germany Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Escitalopram Oxalate Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Escitalopram Oxalate Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Escitalopram Oxalate Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Escitalopram Oxalate Revenue Market Share by Region (2017-2028)
Figure 58. China Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Escitalopram Oxalate Sales Market Share by Type (2017-2028)
Figure 65. South America Escitalopram Oxalate Sales Market Share by Application (2017-2028)
Figure 66. South America Escitalopram Oxalate Sales Market Share by Country (2017-2028)
Figure 67. South America Escitalopram Oxalate Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Escitalopram Oxalate Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Escitalopram Oxalate Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Escitalopram Oxalate Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Escitalopram Oxalate Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Escitalopram Oxalate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Escitalopram Oxalate in 2021
Figure 79. Manufacturing Process Analysis of Escitalopram Oxalate
Figure 80. Escitalopram Oxalate Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のエスシタロプラムシュウ酸塩市場2022年：経口液剤、錠剤、その他(Global Escitalopram Oxalate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のエスシタロプラムシュウ酸塩市場2022年：経口液剤、錠剤、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp